Subscribe To
SILK / Silk Road Medical: Today Best Nearby Cap-Gain Medical Equipment Stock Prospect
SILK News
By The Motley Fool
October 11, 2023
Why Shares of Silk Road Medical Are Dropping Wednesday
Silk Road Medical is a medical device company that focuses on preventing strokes. The company released preliminary third-quarter numbers and reduced y more_horizontal
By Proactive Investors
October 11, 2023
Silk Road Medical stock plummets on CEO exit and revenue downgrade
Silk Road Medical (NASDAQ:SILK) stock halved in value at the start of Wednesday's trading after an after-hours profit warning. The company, which has more_horizontal
By InvestorPlace
October 11, 2023
Why Is Silk Road Medical (SILK) Stock Down 40% Today?
Silk Road Medical (NASDAQ: SILK ) stock is falling hard on Wednesday after the medical device company released preliminary earnings results for Q3 20 more_horizontal
By Barrons
October 11, 2023
Silk Road Medical Stock Sinks. Here's Why Citi Says Sell.
Two pieces of news are weighing on shares of the medical devices company. more_horizontal
By Market Watch
October 10, 2023
Silk Road Medical stock falls following outlook, CEO's retirement
Silk Road Medical Inc. SILK, -0.71% shares dropped in the extended session Tuesday after the medical device company updated its forecast and said its more_horizontal
By GlobeNewsWire
September 4, 2023
Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and i more_horizontal
By Seeking Alpha
August 1, 2023
Silk Road Medical, Inc. (SILK) Q2 2023 Earnings Call Transcript
Silk Road Medical, Inc. (NASDAQ:SILK ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relatio more_horizontal
By Zacks Investment Research
August 1, 2023
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to lo more_horizontal